Despite its potential, nanopharmacology faces several challenges:
Toxicity: The long-term biocompatibility and toxicity of nanoparticles need to be thoroughly evaluated. Regulatory hurdles: Standardizing the production and quality control of nanoparticles is complex. Cost: High production costs can limit the widespread adoption of nanomedicines. Scalability: Manufacturing nanoparticles consistently at a large scale is a significant challenge.